Home/Filings/4/0001104659-23-095018
4//SEC Filing

Peters Richard 4

Accession 0001104659-23-095018

CIK 0001781983other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 9:50 PM ET

Size

17.7 KB

Accession

0001104659-23-095018

Insider Transaction Report

Form 4
Period: 2023-08-23
Transactions
  • Award

    Stock Options (Right to Buy)

    2023-08-23+2,0002,000 total
    Exercise: $3.65Exp: 2033-08-23Common Stock (2,000 underlying)
  • Award

    Common Stock

    2023-08-23+5001,029 total
Footnotes (2)
  • [F1]These shares represent restricted stock units which were granted on August 23, 2023, and which will vest and be settled in common stock on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
  • [F2]The option vests in full on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1
  • filerCIK 0001697628

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 9:50 PM ET
Size
17.7 KB